10: Management of obesity

Joseph Proietto and Louise A Baur
Med J Aust 2004; 180 (9): 474-480.


Improved understanding of the regulation of body weight and activity is leading to new treatment strategies

Please login with your free MJA account to view this article in full

  • Joseph Proietto1
  • Louise A Baur2

  • 1 Department of Medicine, Repatriation Hospital, Melbourne, VIC.
  • 2 Children's Hospital at Westmead, Sydney, NSW.


Competing interests:

J P is chair of the medical advisory board for Optifast (Novartis) and a member of the medical advisory boards for Orlistat (Roche) and Sibutramine (Abbott).

  • 1. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998; 22: 1164-1171.
  • 2. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva, 3-5 June 1997. Geneva: WHO, 1998.
  • 3. Ko GT, Tang J, Chan JC, et al. Lower BMI cut-off value to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance. Br J Nutr 2000; 85: 239-242.
  • 4. Swinburn BA, Ley SJ, Carmichael HE, et al. Body size and composition in Polynesians. Int J Obes Relat Metab Disord 1999; 23: 1178-1183.
  • 5. Han TS, Van Leer EM, Seidell JC, et al. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 1995; 311: 1401-1405.
  • 6. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000; 8: 1-27.
  • 7. National Health and Medical Research Council. Clinical practice guidelines for the management of overweight and obesity in adults. Canberra: NHMRC, 2003.
  • 8. Cole TJ, Bellizzi MC, Flegal KM, et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000; 320: 1240-1243.
  • 9. Maffeis C, Pietrobelli A, Grezzani A, et al. Waist circumference and cardiovascular risk factors in prepubertal children. Obes Res 2001; 9: 179-187.
  • 10. Goran MI, Gower BA. Relation between visceral fat and disease risk in children and adolescents. Am J Clin Nutr 1999; 70: S149-S156.
  • 11. National Heart Foundation of Australia. Risk factor prevalence study No 1. 1980 Canberra: NHF, 1980.
  • 12. Cameron AJ, Welborn TA, Zimmet PZ, et al. Overweight and obesity in Australia: the 1999–2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust 2003; 178: 427-432. <MJA full text>
  • 13. Magarey AM, Daniels LA, Boulton TJ. Prevalence of overweight and obesity in Australian children and adolescents: reassessment of 1985 and 1995 data against new standard international definitions. Med J Aust 2001; 174: 561-564. <MJA full text>
  • 14. Stunkard AJ, Harris JR, Pedersen NL, et al. The body-mass index of twins who have been reared apart. N Engl J Med 1990; 322: 1483-1487.
  • 15. Sorensen TI, Holst C, Stunkard AJ, et al. Correlations of body mass index of adult adoptees and their biological and adoptive relatives. Int J Obes Relat Metab Disord 1992; 16: 227-236.
  • 16. Clement K, Boutin P, Froguel P. Genetics of obesity. Am J Pharmacogenomics 2002; 2: 177-187.
  • 17. Robinson TN. Television viewing and childhood obesity. Pediatr Clin North Am 2001; 48: 1017-1025.
  • 18. Ludwig DS, Peterson KE, Gortmaker SL. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet 2001; 357: 505-508.
  • 19. Jeffery RW. Minnesota studies on community-based approaches to weight loss and control. Ann Intern Med 1993; 119: 719-721.
  • 20. Campbell K, Waters E, O’Meara S, et al. Interventions for preventing obesity in children. Cochrane Database Syst Rev 2002, CD001871.
  • 21. Economos CD, Brownson RC, DeAngelis MA, et al. What lessons have been learned from other attempts to guide social change? Nutrition Reviews 2001; 59: S40-S56.
  • 22. Ludwig DS, Pereira MA, Kroenke CH, et al. Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA 1999; 282: 1539-1546.
  • 23. Brand-Miller J, Foster-Powell K, Colagiuri S. The new glucose revolution. 2nd ed. Sydney: Hodder Headline Australia, 2003.
  • 24. Harvey EL, Glenny A-M, Kirk SFL, Summerbell CD. Improving health professionals' management and the organisation of care for overweight and obese people (Cochrane Review). In: The Cochrane Library, Issue 1, 2004. Chichester, UK: John Wiley and Sons, Ltd.
  • 25. Epstein LH, Valoski A, Wing RR, et al. Ten-year follow-up of behavioral, family-based treatment for obese children. JAMA 1990; 264: 2519-2523.
  • 26. Epstein LH, Cluss PA. A behavioral medicine perspective on adherence to long-term medical regimens. J Consult Clin Psychol 1982; 50: 950-971.
  • 27. Golan M, Weizman A, Apter A, et al. Parents as the exclusive agents of change in the treatment of childhood obesity. Am J Clin Nutr 1998; 67: 1130-1135.
  • 28. Summerbell CD, Waters E, Edmunds L, et al. Interventions for treating obesity in children (protocol for a Cochrane review). The Cochrane Library, 2003. Oxford: Update Software.
  • 29. Brownell KD, Kelman JH, Stunkard AJ. Treatment of obese children with and without their mothers: changes in weight and blood pressure. Pediatrics 1983; 71: 515-523.
  • 30. Saelens BE, Sallis JF, Wilfley DE, et al. Behavioral weight control for overweight adolescents initiated in primary care. Obes Res 2002; 10: 22-32.
  • 31. National Health and Medical Research Council. Clinical practice guidelines for the management of overweight and obesity in children. Canberra: NHMRC, 2003. Available at: (accessed Mar 2004).
  • 32. Burry JN. Obesity and virtue. Is staying lean a matter of ethics? Med J Aust 1999; 171: 609-610. <MJA full text>
  • 33. Scheen AJ. Results of obesity treatment. Ann Endocrinol (Paris) 2002; 63: 163-170.
  • 34. Geldszus R, Mayr B, Horn R, et al. Serum leptin and weight reduction in female obesity. Eur J Endocrinol 1996; 135: 659-662.
  • 35. Montague CT, Farooqi IS, Whitewhead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387: 903-908.
  • 36. Haddock CK, Poston WS, Dill PL, et al. Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials. Int J Obes 2002; 26: 262-273.
  • 37. Torgerson JS, Hauptman J, Boldrin MN, Sjostrom L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004; 27: 155-161.
  • 38. James WP, Astrup A, Finer N, et al. Effect of sibutramine on weight maintenance after weight loss: a randomised trial. STORM Study Group. Sibutramine Trial of Obesity Reduction and Maintenance. Lancet 2000; 356: 2119-2125.
  • 39. Dixon JB, O’Brien PE. Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg 2002; 184: 51S-54S.
  • 40. Sjostrom L. Obesity, diabetes and other cardiovascular risk factors: lessons from SOS. Int J Obes 2000; 24: S7.
  • 41. Dixon JB, O’Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 2002; 25: 358-363.
  • 42. Allen JW, Coleman MG, Fielding GA. Lessons learned from laparoscopic gastric banding for morbid obesity. Am J Surg 2001; 182: 10-14.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.